MORGAN STANLEY PLC/CALL/ZOETIS/185/0.1/17.01.25 Share Price

Warrant

DE000MB35469

Market Closed - Börse Stuttgart 19:32:02 02/07/2024 BST
1.19 EUR +7.21% Intraday chart for MORGAN STANLEY PLC/CALL/ZOETIS/185/0.1/17.01.25
Current month-4.80%
1 month+16.67%
Date Price Change
02/07/24 1.19 +7.21%
01/07/24 1.11 -11.20%
28/06/24 1.25 -3.10%
27/06/24 1.29 +20.56%
26/06/24 1.07 +7.00%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 07:32 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ZOETIS INC.
Issuer Morgan Stanley
WKN MB3546
ISINDE000MB35469
Date issued 02/02/2023
Strike 185 $
Maturity 17/01/2025 (199 Days)
Parity 10 : 1
Emission price 2.48
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 3.81
Lowest since issue 0.46
Delta0.48x
Omega 6.571
Premium13.21x
Gearing13.56x
Moneyness 0.9449
Difference Strike 10.19 $
Difference Strike %+5.51%
Spread 0.02
Spread %1.65%
Theoretical value 1.200
Implied Volatility 29.86 %
Total Loss Probability 59.98 %
Intrinsic value 0.000000
Present value 1.200
Break even 197.89 €
Theta-0.03x
Vega0.05x
Rho0.04x

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
174.8 USD
Average target price
210.2 USD
Spread / Average Target
+20.22%
Consensus